Monograph Details
|
|
Cardiovascular System
> Hypertension
|
|
TARKA 2/180 |
| Manufacturer |
|
Abbott Laboratories |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
ACE inhibitor + calcium channel blocker (diphenylalkylamine). |
| Generic Name |
|
Trandolapril 2mg, verapamil HCl 180mg (ext-rel); tabs. |
| Also |
• TARKA 1/240
• TARKA 2/240
• TARKA 4/240
|
| Indications |
|
Hypertension. |
| Children |
|
<18yrs: not recommended. |
| Adults |
|
Not for initial therapy. Titrate individual components. Take with food. ≥18yrs: 1 tab daily. |
| Contraindications |
|
History of ACEI-associated angioedema. Severe left ventricular (LV) dysfunction or LV dysfunction treated with β-blockers. Moderate to severe heart failure. Hypotension. Cardiogenic shock. Sick sinus syndrome, 2nd- or 3rd-degree AV block, unless paced. Atrial flutter or fibrillation and an accessory bypass tract. Pregnancy (Cat.D in 2nd and 3rd trimesters). |
| Precautions |
|
Discontinue if laryngeal edema, angioedema, or jaundice occurs. Hepatic or renal dysfunction. Salt/volume depletion. CHF. Renal artery or aortic stenosis. Cerebrovascular or ischemic heart disease. Monitor liver function. Monitor for neutropenia in collagen vascular and/or renal disease and for hyperkalemia in diabetics. Dialysis (esp. high-flux membrane). Surgery. Black patients may have higher risk of angioedema than non-black patients. Control mild heart failure (eg, with digitalis, diuretics). AV conduction or neuromuscular transmission disorders. Hypertrophic cardiomyopathy. Pregnancy (Cat.C in 1st trimester). Nursing mothers: not recommended. |
| Interactions |
|
For trandolapril: Excessive hypotension with diuretics. Hyperkalemia with K+ supplements, K+-sparing diuretics, salt substitutes. May increase lithium levels. For verapamil: Potentiates alcohol, β-blockers, other antihypertensives, digitalis, theophylline, neuromuscular blockers, flecainide, carbamazepine, cyclosporine. Potentiated by grapefruit juice. Avoid disopyramide; quinidine in cardiomyopathy. Potentiated by CYP3A4 inhibitors (eg, erythromycin, ritonavir); antagonized by CYP3A4 inducers (eg, rifampin). Inhalation anesthetics may potentiate cardiac depression. May increase bleeding with aspirin. Monitor theophylline, lithium. |
| Adverse Reactions |
|
Cough, AV block, constipation, dizziness, elevated liver enzymes, fatigue, chest pain, bradycardia, joint pain, GI upset, bronchitis, dyspnea, pain in extremities, paralytic ileus. |
| How Supplied |
|
Tabs—100 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
